Company intelligence
Pivotal
The Next Generation CRO | Biotech Full-Service CRO & Oncology Clinical Trials
About Pivotal
Our vision is to be the most customer-centric CRO on earth. We know that biotech and pharma companies look for ways to accelerate clinical trial execution, so we deliver faster, smarter, scientific and affordable clinical development solutions. Founded in 2001 by Dr. Ibrahim Farr, Pivotal is a full-service CRO headquartered in Madrid, operating in more than 27 countries with some 220 employees. We have built focused specialization across all therapeutic areas, with a strong hub in oncology clinical trials, innovative therapies and early phase clinical trials. As a data-driven CRO, we leverage our near real-time advanced analytics platform to discover insights that anticipate trial risks and predict their impact making us an efficient, agile and resilient partner for Phase I, II, III and IV clinical trials. Our Innovative Organizational Model connects scientific, medical and technological expertise to deliver patient-centric and PI-centric trials that reduce timelines, cut costs and maximize our clients' drug development value.
Verified activity
Signals from Pivotal
4 published signals
Legal & Regulatory
Pivotal achieved official Medidata TSDV accreditation as of 14 July 2026.
Reported by Pivotal
Presence & Recognition
Pivotal received an abstract submission from Rob King for an oral presentation at the Charlotte Biomedical Symposium on September 14th.
Reported by Pivotal
Presence & Recognition
Pivotal Chairman and CEO Ibrahim Farr will speak at CRO Summit Europe 2026 on September 15-16 at the Novotel Amsterdam City, opening Section E of the Keynote C-Suite Panel.
Reported by Pivotal
Presence & Recognition
Pivotal is promoting the Charlotte Biomedical Symposium on September 14th.
Reported by Rob King